Nephrotoxic effects in high-risk patients undergoing angiography.

被引:789
作者
Aspelin, P [1 ]
Aubry, P
Fransson, S
Strasser, R
Willenbrock, R
Berg, KJ
机构
[1] Huddinge Univ Hosp, Dept Radiol, S-14186 Huddinge, Sweden
[2] CHU Bichat, Dept Cardiol, Paris, France
[3] Linkoping Univ Hosp, Dept Thorac Radiol, S-58185 Linkoping, Sweden
[4] Tech Univ, Kardiol Herzzentrum, Med Klin 2, Dresden, Germany
[5] Helios Kliniken, Franz Volhard Klin, Dept Cardiol, Berlin, Germany
[6] Univ Oslo, Rikshosp, Lab Renal Physiol, N-0027 Oslo, Norway
关键词
D O I
10.1056/NEJMoa021833
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The use of iodinated contrast medium can result in nephropathy. Whether iso-osmolar contrast medium is less nephrotoxic than low-osmolar contrast medium in high-risk patients is uncertain. Methods: We conducted a randomized, double-blind, prospective, multicenter study comparing the nephrotoxic effects of an iso-osmolar, dimeric, nonionic contrast medium, iodixanol, with those of a low-osmolar, nonionic, monomeric contrast medium, iohexol. The study involved 129 patients with diabetes with serum creatinine concentrations of 1.5 to 3.5 mg per deciliter who underwent coronary or aortofemoral angiography. The primary end point was the peak increase from base line in the creatinine concentration during the three days after angiography. Other end points were an increase in the creatinine concentration of 0.5 mg per deciliter or more, an increase of 1.0 mg per deciliter or more, and a change in the creatinine concentration from day 0 to day 7. Results: The creatinine concentration increased significantly less in patients who received iodixanol. From day 0 to day 3, the mean peak increase in creatinine was 0.13 mg per deciliter in the iodixanol group and 0.55 mg per deciliter in the iohexol group (P=0.001; the increase with iodixanol minus the increase with iohexol, -0.42 mg per deciliter [95 percent confidence interval, -0.73 to -0.22]). Two of the 64 patients in the iodixanol group (3 percent) had an increase in the creatinine concentration of 0.5 mg per deciliter or more, as compared with 17 of the 65 patients in the iohexol group (26 percent) (P=0.002; odds ratio for such an increase in the iodixanol group, 0.09 [95 percent confidence interval, 0.02 to 0.41]). No patient receiving iodixanol had an increase of 1.0 mg per deciliter or more, but 10 patients in the iohexol group (15 percent) did. The mean change in the creatinine concentration from day 0 to day 7 was 0.07 mg per deciliter in the iodixanol group and 0.24 mg per deciliter in the iohexol group (P=0.003; value in the iodixanol group minus the value in the iohexol group, -0.17 mg per deciliter [95 percent confidence interval, -0.34 to -0.07]). Conclusions: Nephropathy induced by contrast medium may be less likely to develop in high-risk patients when iodixanol is used rather than a low-osmolar, nonionic contrast medium.
引用
收藏
页码:491 / 499
页数:9
相关论文
共 47 条
  • [11] Randomized trial of contrast media utilization in high-risk PTCA - The COURT trial
    Davidson, CJ
    Laskey, WK
    Hermiller, JB
    Harrison, JK
    Matthai, W
    Vlietstra, RE
    Brinker, JA
    Kereiakes, DJ
    Muhlestein, JB
    Lansky, A
    Popma, JJ
    Buchbinder, M
    [J]. CIRCULATION, 2000, 101 (18) : 2172 - 2177
  • [12] Renal effects of low and isoosmolar contrast media on renal hemodynamic in a normal and ischemic dog kidney
    Deray, G
    Bagnis, C
    Jacquiaud, C
    Dubois, M
    Adabra, Y
    Jaudon, C
    [J]. INVESTIGATIVE RADIOLOGY, 1999, 34 (01) : 1 - 4
  • [13] Acetylcysteine to prevent angiography-related renal tissue injury (the APART Trial)
    Diaz-Sandoval, LJ
    Kosowsky, BD
    Losordo, DW
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (03) : 356 - +
  • [14] Efron B., 1993, INTRO BOOTSTRAP, V1st ed., DOI DOI 10.1201/9780429246593
  • [15] Erickson CW, 2002, AM J KIDNEY DIS, V39, pA16
  • [16] Contrast medium-induced nephrotoxicity: Pathophysiology and prevention
    Gerlach, AT
    Pickworth, KK
    [J]. PHARMACOTHERAPY, 2000, 20 (05): : 540 - 548
  • [17] Main results of the first comparative clinical studies on visipaque - An overview of 18 clinical studies
    Grynne, BH
    Nossen, JO
    Bolstad, B
    Borch, KW
    [J]. ACTA RADIOLOGICA, 1995, 36 : 265 - 270
  • [18] Pathophysiology of radiocontrast nephropathy - A role for medullary hypoxia
    Heyman, SN
    Reichman, J
    Brezis, M
    [J]. INVESTIGATIVE RADIOLOGY, 1999, 34 (11) : 685 - 691
  • [19] Renal experience with Visipaque
    Jakobsen, JA
    [J]. EUROPEAN RADIOLOGY, 1996, 6 : S16 - S19
  • [20] Jakobsen JA, 1996, NEPHRON, V73, P549